<?xml version="1.0" encoding="UTF-8"?>
<compound>
  <id type="integer">346448</id>
  <title nil="true"/>
  <common-name>Ethyl 2-[(4e)-4-[(4-butoxyphenyl)-hydroxymethylidene]-2,3-dioxo-5-pyridin-3-ylpyrrolidin-1-yl]-4-methyl-1,3-thiazole-5-carboxylate</common-name>
  <description>Ethyl 2-[(4e)-4-[(4-butoxyphenyl)-hydroxymethylidene]-2,3-dioxo-5-pyridin-3-ylpyrrolidin-1-yl]-4-methyl-1,3-thiazole-5-carboxylate is a chemical compound with the formula C27H27N3O6S. With an average molecular weight of 521.60 g/mol, Ethyl 2-[(4e)-4-[(4-butoxyphenyl)-hydroxymethylidene]-2,3-dioxo-5-pyridin-3-ylpyrrolidin-1-yl]-4-methyl-1,3-thiazole-5-carboxylate is a heavy molecule.</description>
  <cas>609796-51-2</cas>
  <pubchem-id>5894804</pubchem-id>
  <chemical-formula>C27H27N3O6S</chemical-formula>
  <weight>521.6</weight>
  <appearance nil="true"/>
  <melting-point nil="true"/>
  <boiling-point nil="true"/>
  <density nil="true"/>
  <solubility nil="true"/>
  <specific-gravity nil="true"/>
  <flash-point nil="true"/>
  <vapour-pressure nil="true"/>
  <route-of-exposure nil="true"/>
  <target nil="true"/>
  <mechanism-of-toxicity nil="true"/>
  <metabolism nil="true"/>
  <toxicity nil="true"/>
  <lethaldose nil="true"/>
  <carcinogenicity nil="true"/>
  <use-source nil="true"/>
  <min-risk-level nil="true"/>
  <health-effects nil="true"/>
  <symptoms nil="true"/>
  <treatment nil="true"/>
  <created-at type="dateTime">2026-08-31T09:53:46Z</created-at>
  <updated-at type="dateTime">2026-08-31T09:53:46Z</updated-at>
  <interacting-proteins nil="true"/>
  <wikipedia nil="true"/>
  <uniprot-id nil="true"/>
  <kegg-compound-id nil="true"/>
  <omim-id nil="true"/>
  <chebi-id nil="true"/>
  <biocyc-id nil="true"/>
  <ctd-id nil="true"/>
  <stitch-id nil="true"/>
  <drugbank-id nil="true"/>
  <pdb-id nil="true"/>
  <actor-id nil="true"/>
  <organism nil="true"/>
  <export type="boolean">true</export>
  <metabolizing-proteins nil="true"/>
  <transporting-proteins nil="true"/>
  <moldb-smiles>CCCCOC1=CC=C(C=C1)C(=C2C(N(C(=O)C2=O)C3=NC(=C(S3)C(=O)OCC)C)C4=CN=CC=C4)O</moldb-smiles>
  <moldb-formula>C27H27N3O6S</moldb-formula>
  <moldb-inchi>InChI=1S/C27H27N3O6S/c1-4-6-14-36-19-11-9-17(10-12-19)22(31)20-21(18-8-7-13-28-15-18)30(25(33)23(20)32)27-29-16(3)24(37-27)26(34)35-5-2/h7-13,15,21,31H,4-6,14H2,1-3H3/b22-20+</moldb-inchi>
  <moldb-inchikey>FOZCXYPBVAMDQA-LSDHQDQOSA-N</moldb-inchikey>
  <moldb-average-mass type="decimal" nil="true"/>
  <moldb-mono-mass type="decimal">521.1620568</moldb-mono-mass>
  <origin nil="true"/>
  <state nil="true"/>
  <logp>5</logp>
  <hmdb-id nil="true"/>
  <chembl-id nil="true"/>
  <chemspider-id nil="true"/>
  <structure-image-file-name nil="true"/>
  <structure-image-content-type nil="true"/>
  <structure-image-file-size type="integer" nil="true"/>
  <structure-image-updated-at type="dateTime" nil="true"/>
  <biodb-id nil="true"/>
  <synthesis-reference nil="true"/>
  <structure-image-caption nil="true"/>
  <chemdb-id>CHEM342341</chemdb-id>
  <dsstox-id nil="true"/>
  <toxcast-id nil="true"/>
  <stoff-ident-origin nil="true"/>
  <stoff-ident-id nil="true"/>
  <susdat-id nil="true"/>
  <iupac>Ethyl 2-[(4e)-4-[(4-butoxyphenyl)-hydroxymethylidene]-2,3-dioxo-5-pyridin-3-ylpyrrolidin-1-yl]-4-methyl-1,3-thiazole-5-carboxylate</iupac>
  <moldb-polar-surface-area nil="true"/>
  <moldb-refractivity nil="true"/>
  <moldb-polarizability nil="true"/>
  <moldb-rotatable-bond-count nil="true"/>
  <moldb-acceptor-count nil="true"/>
  <moldb-donor-count nil="true"/>
  <moldb-pka-strongest-acidic nil="true"/>
  <moldb-pka-strongest-basic nil="true"/>
  <moldb-physiological-charge nil="true"/>
  <moldb-number-of-rings nil="true"/>
  <moldb-alogps-logp nil="true"/>
  <moldb-alogps-logs nil="true"/>
  <moldb-alogps-solubility nil="true"/>
  <kingdom>Organic compounds</kingdom>
  <superklass>Organoheterocyclic compounds</superklass>
  <klass>Pyridines and derivatives</klass>
  <subklass>Pyrrolidinylpyridines</subklass>
  <paper-count type="integer" nil="true"/>
  <sync-id>CED0296801</sync-id>
  <structure-inchikey>FOZCXYPBVAMDQA-UHFFFAOYSA-N</structure-inchikey>
  <structure-fingerprint>40000000000400000800802000000000050002010000000000000000000000000000002000020200000000000002004008000000004000000000000000000000000000000000000030000000000000020000010000100000200000004010000041020010020100400000000010000000000000100000000000000001000101020100040000000800000440000000000000000000000000000020020000101000000000000000000000000084000000008100000080000080000000000000100000040000020005000000000000001000000004000002000000200000000000000000000000001002040000000010420000000000000000000000000000000</structure-fingerprint>
  <structure-pattern-fingerprint>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</structure-pattern-fingerprint>
  <structure-pickle type="binary" encoding="base64">776t3gAAAAAQAAAAAwAAAAAAAAAlAAAAKAAAAIABBgBgAAAAAQMGAGAAAAAC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</structure-pickle>
  <structure-indexed-at type="dateTime">2026-09-19T05:45:11Z</structure-indexed-at>
</compound>
